Advertisement
HomeCollectionsGenetic Therapy
IN THE NEWS

Genetic Therapy

BUSINESS
By Kim Clark and Kim Clark,Staff Writer | September 11, 1993
Genetic Therapy Inc. said yesterday that it had won initial federal approval for clinical trials of three experimental anti-cancer treatments, including a second round of tests of genetically altered mouse cells used to fight brain tumors.The Recombinant DNA Advisory Committee of the National Institutes of Health said the Gaithersburg-based biotechnology company could now test its brain cancer therapy on children.The committee, which rules on all genetic testing, said the company also could start trials injecting genetically altered viruses into patients undergoing bone marrow transplants for the treatment of breast cancer.
Advertisement
BUSINESS
December 13, 1993
New positions* Comcast Cablevision appointed Barbara A. Gehrig as regional vice president for finance.* Towson Town Center named Gregory Walton assistant manager and Leigh Keiser an assistant marketing director.* Phillips Publishing International named Pablo Varela general manager of its printing and fulfillment services division.* AlliedSignal Technical Services Corp., of Columbia, selected Rosemarie Mecca as director of health information services.Legal and professional* Katz, Abosch, Windesheim, Gershman & Freedman, Baltimore-based accountants and management consultants, announced that Deborah Edmonds and Christine Mayer have joined the firm as staff accountants.
BUSINESS
By Liz Bowie and Liz Bowie,Staff Writer | April 19, 1992
When M. James Barrett knocked on the doors of big drug companies in 1987, he was peddling dreams.He had no magic cure in a vial, no recipe for a drug, just a good hunch that a technique called gene therapy could revolutionize the way diseases are treated."
BUSINESS
By LIZ BOWIE and LIZ BOWIE,STAFF WRITER | March 9, 1993
Md. companies vie in gene therapy raceAn interesting race appears to be developing between two Maryland companies to treat cystic fibrosis by using gene therapy.The competitors: Genetic Therapy Inc. of Gaithersburg, a well-established company, and GenVec Inc., which was founded just last week.GenVec, based in a small temporary office in Rockville, has a solid financial and scientific foundation. It is backed by $24 million, including $13 million from Genentech Inc., and boasts the expertise of a top National Institutes of Health researcher -- which could make it a potent force in the industry.
BUSINESS
January 29, 1993
Macy to close more storesR. H. Macy & Co. Inc. said yesterday that it expected to close several more underperforming department stores this year, with a decision on which branches to be shut coming by early March.Genetic Therapy cuts offeringGenetic Therapy Inc. of Gaithersburg said yesterday that its offering of 1.5 million shares was priced at $10 a share. The company had planned to sell 2 million shares and price them as high as $14 a share.Analysts said they believed the lower pricing and number of shares reflected a decline in biotechnology stocks in the past few days as well as a large number of public offerings this month.
BUSINESS
January 30, 1993
Marriott bondholders hire adviserMarriott Corp. bondholders hired financial advisers Whitman Heffernan Rhein & Co. Inc. to help them fight the hotel company's controversial restructuring, according to Whitman Heffernan Vice President Ed Whiting. A group of institutional bondholders led by PPM America Inc., which owns about $120 million of Marriott bonds, hired the firm to analyze Marriott's plan.Baxter rents Russell St. buildingBaxter International leased 42,000 square feet of a Russell Street building, in which the company plans to open a specialized laundry service aimed at the hospital and health-care business.
BUSINESS
By New York Times News Service | February 14, 1992
SAN FRANCISCO -- A federal review panel has cleared the way for the first commercial test of gene therapy, a potentially revolutionary technique that could cure hereditary diseases and might also help in fighting diseases such as AIDS and cancer.The Recombinant Advisory Committee of the National Institutes of Health, which oversees gene therapy experiments, gave permission Tuesday to researchers associated with Seattle-based Targeted Genetics Corp. to implant genetically modified cells into patients with acquired immune deficiency syndrome in hopes of helping them fight the disease.
BUSINESS
September 27, 1994
McDonnell Douglas names CEOMcDonnell Douglas Corp. named Harry C. Stonecipher as chief executive and president yesterday, ending 102 years of family leadership and capping a five-year restructuring that has restored the St. Louis-based aerospace company to health.Mr. Stonecipher, 58, was chairman and chief executive of the Sundstrand Corp., a maker of aircraft components and industrial power systems in Rockford, Ill., that has come back under his leadership from a devastating military overbilling-fraud scandal in the late 1980s.
BUSINESS
By Timothy J. Mullaney and Timothy J. Mullaney,Sun Staff Writer | September 2, 1995
Genetic Therapy Inc. of Gaithersburg is Maryland's fastest-growing biotechnology company, and a Beltsville-based Internet access provider, Digital Express Group Inc., is the fastest-growing information company in the state, according to the new "Fast 40" list released yesterday by the Greater Baltimore Committee.The list promotes young and often little-known companies by recognizing their early accomplishments, in hopes that the spotlight will help them attract venture capital and make contacts with investment bankers, said Victor Hoskins, assistant secretary for marketing at the state Department of Business and Economic Development.
BUSINESS
By Liz Bowie and Liz Bowie,Staff Writer | March 2, 1993
BETHESDA -- The Johns Hopkins School of Medicine received preliminary approval yesterday to conduct its first gene therapy experiment on 26 kidney cancer patients who have little chance of survival.The National Institutes of Health advisory committee gave the Hopkins researchers the approval to do an experiment to determine whether the therapy was safe.The committee also approved other gene therapy experiments for brain cancer and leukemia in children, which will be done in Des Moines, Iowa, and Memphis, Tenn.
Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.